Marisol Valenzuela-Lara

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
BACKGROUND WHO has developed a global HIV-drug resistance surveillance strategy, including assessment of pretreatment HIV-drug resistance. We aimed to do a nationally representative survey of pretreatment HIV-drug resistance in Mexico using WHO-recommended methods. METHODS Among 161 Ministry of Health antiretroviral therapy (ART) clinics in Mexico, the(More)
O225 Table 1. Baseline characteristics of study population Total (n 127) Naı̈ve patients (n 100) Treated patients (n 27) Sex Male 103 (81.1) 87 (87.0) 16 (59.3) Age at diagnosis Median (IQR) 40 (30 to 50) 47 (31 to 50) 34 (25 to 43) Year of diagnosis Median (IQR) 2012 (2009 to 2015) 2014 (2012 to 2015) 2005 (2000 to 2011) Country of origin Aruba 74 (58.3)(More)
  • 1